ArticleActa pharmaceutica Sinica. B2026

pH-Activatable engineered nanoparticle-based selective hexokinase 2 degrader provokes GSDME-dependent pyroptosis for cancer therapy.

Linlin Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.